Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 26, 2023

BUY
$135.66 - $197.02 $179,749 - $261,051
1,325 Added 860.39%
1,479 $227,000
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $179,749 - $261,051
-1,325 Reduced 89.59%
154 $23,000
Q4 2022

Mar 08, 2023

BUY
$118.38 - $210.04 $175,084 - $310,649
1,479 New
1,479 $265,000
Q1 2022

May 02, 2022

SELL
$126.46 - $235.05 $290,858 - $540,615
-2,300 Reduced 60.86%
1,479 $255,000
Q4 2021

Jan 20, 2022

SELL
$225.82 - $368.51 $4,742 - $7,738
-21 Reduced 0.55%
3,779 $960,000
Q1 2021

Apr 23, 2021

BUY
$109.18 - $185.98 $120,098 - $204,578
1,100 Added 40.74%
3,800 $498,000
Q4 2020

Jan 13, 2021

BUY
$65.74 - $169.86 $177,498 - $458,622
2,700 New
2,700 $282,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sheets Smith Wealth Management Portfolio

Follow Sheets Smith Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.